Tacit Therapeutics

Private

South San Francisco, CaliforniaHealthcare & Life Scienceshttps://tacittx.com/

Last Round

Series A

Mar 9, 2026

Total Funding Raised

$29.5M

Company Overview

Tacit Therapeutics is a biotechnology company that develops RNA-targeted treatments to repair mutated genes using its proprietary Splicing-Directed Repair™ technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

RNA therapeuticsRNA trans-splicinggenetic medicineneurological diseasedrug discoverybiotechprecision medicineRNA editinggene therapysynthetic biologyAI drug discoverypre-clinical researchbiotech platformtherapeutic pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Tacit Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Tacit Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Tacit Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Mar 9, 2026
Grant	Jan 15, 2024
Series A	Jun 8, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

David Nelles

CEO, Founder

Founding Team

Tacit Therapeutics Investors

Notable investors and investment history

Tacit Therapeutics investors
Investor	Rounds
Mitsui Global Investment	Series A
Eisai Innovation	Series A
Michigan Capital Network	Series A
Civilization Ventures	Series A
KdT Ventures	Series A
National Science Foundation	Grant

View all Investors

Tacit Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Tacit Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Tacit Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth San Francisco, California

Employee Range13

Year Founded2021

Last FundingMar 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.